Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects
- Authors
- Kim, Mi-Hwa; Cho, Goang-Won; Koh, Seong-Ho; Huh, Yong-Min; Kim, Seung Hyun
- Issue Date
- Aug-2010
- Publisher
- MAIK NAUKA/INTERPERIODICA/SPRINGER
- Keywords
- bone marrow mesenchymal stromal cells; erythropoietin; cell protection
- Citation
- MOLECULAR BIOLOGY, v.44, no.4, pp.577 - 584
- Indexed
- SCIE
SCOPUS
- Journal Title
- MOLECULAR BIOLOGY
- Volume
- 44
- Number
- 4
- Start Page
- 577
- End Page
- 584
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/174400
- DOI
- 10.1134/S0026893310040126
- ISSN
- 0026-8933
- Abstract
- Human bone marrow mesenchymal stromal cells (hBM-MSCs) are a promising tools for cell therapy. However, the poor viability of the transplanted cells is a major limiting factor. Human erythropoietin (hEPO) has been extensively studied in non-hematopoietic tissues for its neurotrophic, anti-oxidant, antiapoptotic, and anti-inflammatory effects. In this study, we evaluate whether transduction of the hEPO gene into MSCs provides protection and affects their migration. hBM-MSCs transduced with the hEPO gene (EPO-MSCs) stably secreted high levels of hEPO (10 IU/ml) with no alteration of their mesenchymal phenotype. MSCs were also treated with 10 IU rhEPO, an amount similar to what was secreted by EPO-MSCs, to generate 10U-MSCs. Protection against H2O2-induced oxidative stress and staurosporine-induced apoptosis was registered for both EPO-MSCs and 10U-MSCs, but the protective effects were higher for the EPO-MSCs than for the 10U-MSCs. EPO-MSCs had significantly higher migration rates compared to MSCs and 10U-MSCs. We confirmed that the intracellular signaling of ERK1/2 was higher in the EPO-MSCs than 10U-MSCs. This data demonstrates that the endogenous expression of EPO may efficiently initiate the ERK1/2 signaling pathway, resulting in synergistic effects on the production of neurotrophic factors. Thus, EPO-MSCs are a good candidate for cell therapy in ischemic and neurodegenerative diseases.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 신경과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.